About Curative Biotech
Curative Biotech is a publicly listed company based in Boca Raton (United States) founded in 1995. Therapeutic drugs for cancer, eye, and infectious diseases are developed. Curative Biotech offers products and services including Drug Pipeline, Therapeutic Assets, and Neuro Oncology Drugs. Its focus areas include Life Sciences, Ophthalmology, Drugs and Retinal Disorders. Its legal entity is Curative Biotechnology Inc. Its competitors include EyePoint Pharmaceuticals, Rezolute and Imvax; 1 of its 3 listed competitors has raised funding.
Company details
Curative Biotech was founded in 1995 in Boca Raton, United States, within the biotechnology sector. Focus is placed on developing therapeutic drugs targeting cancer, eye conditions, and infectious diseases. The pipeline includes candidates such as IMT504, an oligodeoxynucleotide for rabies treatment; CURB906, a fully humanized CD56 monoclonal antibody for brain tumors; and a reformulated metformin for degenerative eye disease. Operations center on drug candidate advancement for clinical applications.
- Headquarters Boca Raton, United States
- Stage Public
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website curativebiotech.com
- Social LinkedIn X
- Legal Name Curative Biotechnology Inc.
- Net Profit-$2.26 M (USD)34.13as on Dec 31, 2025
- EBITDA-$1.41 M (USD)37.56as on Dec 31, 2025
- Latest Funding Round$146K (USD), Post-IPO
Jan 2023
Products & Services of Curative Biotech
Curative Biotech offers a comprehensive portfolio of products and services, including Drug Pipeline, Therapeutic Assets, and Neuro Oncology Drugs.
Develops candidates for rare diseases like eye disorders
Targets infectious disease treatments through acquisition
Focuses on cancer-related drug candidates for rare indications
Funding Insights of Curative Biotech
- Total Rounds 1
- Last Round Post-IPO — $146,000
- First Round $146,000
(Jan 2023)
All 1 funding rounds of Curative Biotech with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2023 | $146,000 | Post-IPO | – | – | – |
IPO & Listings of Curative Biotech
Curative Biotech is a publicly listed company on the OTC with ticker symbol CUBT in USA, operating in the Distribution services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date22 Feb 2008
- Listed onOTCMKTS: CUBT
- Listed entityCURATIVE BIOTECHNOLOGY INC.
- Exchange sectorDistribution services
- ISINUS23128N3061
- Share price$0.95 · 2026-10-13
- Market capitalisation$6.5M
- EPS (diluted, trailing year)$-0.40
- Volume (last session)600
Financials of Curative Biotech
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | -$2.3M | -$1.4M | |
| 2024 | -$3.4M | -$2.3M | |
| 2023 | -$4.0M | -$1.8M | |
| 2022 | -$5.4M | -$4.4M | |
| 2021 | -$5.3M | -$5.0M |
Detailed financial statements for Curative Biotech
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Curative Biotech
3 dated milestones of Curative Biotech across 28 years, from founding to its latest funding, stage changes and deals.
- Founded Curative Biotech is founded.
- IPO Lists on the stock exchange (IPO).
- Funding First funding round of $146K.
Competitors of Curative Biotech
Curative Biotech has 3 listed competitors in our database, 1 of them funded. They include EyePoint Pharmaceuticals, Rezolute and Imvax.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| eyepointpharma.com | 1987 | Watertown, United States | 49 | Small molecule therapeutics for ophthalmic disorders are developed. | ||
| rezolutebio.com | 2012 | Denver, United States | 51 | Therapies for metabolic and orphan diseases are developed by Rezolute. | ||
| imvax.com | 2015 | Philadelphia, United States | $203.83M | 50 | Patient-specific cell vaccines for glioma treatment are developed. |
Detailed competitors of Curative Biotech
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Curative Biotech
The website of Curative Biotech (curativebiotech.com) receives about 3.5K visits a month.
- Monthly visits3.5K
▲ 77.7% vs previous month
Top companies in Ophthalmology
3 companies that operate in the same segment as Curative Biotech (Ophthalmology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of a wide range of eye care products | 1945 | Fort Worth, Texas, United States | USD 171.61 M | USD 9.64 B | 25,600 | |
Genetic medicines are developed by 4DMT for transformative therapies. | 2013 | Emeryville, California, United States | USD 186.59 M | USD 85.21 M | 227 | |
Developer of antibodies to treat complement-mediated neurodegenerative diseases | 2011 | San Francisco, California, United States | USD 256 M | 100 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Curative Biotech
Complete news archive for Curative Biotech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Curative Biotech
Curative Biotech was founded in 1995 and raised its 1st funding round 28 years after it was founded.
Curative Biotech is headquartered in Boca Raton, United States. It is registered at Boca Raton, Florida, United States.
Curative Biotech was founded in 1995 in Boca Raton, United States, within the biotechnology sector. Focus is placed on developing therapeutic drugs targeting cancer, eye conditions, and infectious diseases. The pipeline includes candidates such as IMT504, an oligodeoxynucleotide for rabies treatment; CURB906, a fully humanized CD56 monoclonal antibody for brain tumors; and a reformulated metformin for degenerative eye disease. Operations center on drug candidate advancement for clinical applications.
Curative Biotech's top competitors include EyePoint Pharmaceuticals, Rezolute and Imvax.
Curative Biotech offers Drug Pipeline, Therapeutic Assets, and Neuro Oncology Drugs.
Yes, Curative Biotech is publicly traded on OTC under the ticker symbol CUBT.
Curative Biotech operates through Curative Biotechnology Inc.